Colonial Trust’s Pfizer PFE Stock Holding History

Colonial Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$689K	Sell	28,616 -4,461	-13%	-$117K	0.09%	150
2026 Q1	$929K	Sell	33,077 -3,278	-9%	-$87.3K	0.13%	124
2025 Q4	$905K	Buy	36,355 +2,540	+8%	+$64.1K	0.12%	130
2025 Q3	$862K	Sell	33,815 -39	-0.1%	-$963	0.12%	139
2025 Q2	$821K	Sell	33,854 -4,762	-12%	-$111K	0.12%	132
2025 Q1	$979K	Sell	38,616 -7,086	-16%	-$185K	0.15%	120
2024 Q4	$1.21M	Sell	45,702 -331	-0.7%	-$8.98K	0.18%	107
2024 Q3	$1.33M	Sell	46,033 -4,520	-9%	-$132K	0.21%	101
2024 Q2	$1.41M	Buy	50,553 +4,523	+10%	+$125K	0.25%	90
2024 Q1	$1.28M	Sell	46,030 -4,743	-9%	-$132K	0.24%	91
2023 Q4	$1.46M	Sell	50,773 -6,982	-12%	-$211K	0.3%	82
2023 Q3	$1.92M	Buy	57,755 +879	+2%	+$31.1K	0.47%	57
2023 Q2	$2.09M	Buy	56,876 +1,176	+2%	+$45.8K	0.5%	58
2023 Q1	$2.27M	Sell	55,700 -885	-2%	-$38.2K	0.58%	52
2022 Q4	$2.9M	Sell	56,585 -720	-1%	-$34.5K	0.79%	34
2022 Q3	$2.51M	Buy	+57,305	New	+$2.78M	0.8%	39

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Colonial Trust's PFE Position: Q2 2026 in Review

Colonial Trust reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $117K and leaving 28,616 shares worth $689K. The position accounts for 0.09% of the portfolio, ranked #150.

Colonial Trust first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.9M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Colonial Trust held 28,616 shares of Pfizer worth $689K as of Q2 2026.
Colonial Trust sold 4,461 Pfizer shares in Q2 2026, an estimated $117K.
Pfizer made up 0.09% of Colonial Trust's portfolio in Q2 2026, its #150 holding.
Colonial Trust first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
Colonial Trust's Pfizer position peaked at $2.9M in Q4 2022.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.